Ariel Investments - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 29 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Ariel Investments ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q2 2021$34,000
-94.7%
12,033
-94.3%
0.00%
-100.0%
Q1 2021$643,000
-73.5%
212,370
-74.1%
0.01%
-77.8%
Q4 2020$2,422,000
-3.6%
821,096
+4.9%
0.03%
-25.0%
Q3 2020$2,512,000
-3.6%
782,4410.0%0.04%
-10.0%
Q2 2020$2,606,000
-33.8%
782,441
-27.8%
0.04%
-42.0%
Q1 2020$3,936,000
-24.4%
1,084,223
+7.3%
0.07%
+6.2%
Q4 2019$5,203,000
-8.4%
1,010,220
+5.4%
0.06%
-14.5%
Q3 2019$5,683,000
-30.4%
958,319
-25.2%
0.08%
-25.5%
Q2 2019$8,161,000
+17.1%
1,281,104
+6.8%
0.10%
+17.2%
Q1 2019$6,970,000
-2.0%
1,199,707
+1.7%
0.09%
-12.1%
Q4 2018$7,114,000
-3.4%
1,179,803
-8.6%
0.10%
+20.7%
Q3 2018$7,368,000
-7.9%
1,290,317
-1.1%
0.08%
-8.9%
Q2 2018$8,000,000
+18.1%
1,305,052
+28.7%
0.09%
+16.9%
Q1 2018$6,773,000
+1.1%
1,013,926
+11.4%
0.08%
+1.3%
Q4 2017$6,698,000
+6.9%
910,076
+2.6%
0.08%
+4.1%
Q3 2017$6,263,000
-8.4%
887,144
-9.1%
0.07%
-9.9%
Q2 2017$6,835,000
-29.3%
976,377
-29.9%
0.08%
-28.9%
Q1 2017$9,668,000
-3.7%
1,393,125
-23.6%
0.11%
-3.4%
Q4 2016$10,035,000
-2.3%
1,824,580
-11.0%
0.12%
-4.8%
Q3 2016$10,269,000
+14.5%
2,049,760
+2.9%
0.12%
+9.7%
Q2 2016$8,967,000
+1.0%
1,992,613
+0.8%
0.11%
+5.6%
Q1 2016$8,875,000
+19.1%
1,976,671
+39.5%
0.11%
+20.2%
Q4 2015$7,452,000
-13.0%
1,416,660
-4.5%
0.09%
-16.8%
Q3 2015$8,563,000
-20.4%
1,484,096
-1.4%
0.11%
-11.6%
Q2 2015$10,761,000
-15.3%
1,505,086
-21.1%
0.12%
-14.8%
Q1 2015$12,702,000
+1.9%
1,907,242
-8.5%
0.14%
-1.4%
Q4 2014$12,471,000
-3.2%
2,085,426
-20.0%
0.14%
-13.3%
Q3 2014$12,880,000
+7.5%
2,607,251
-2.1%
0.17%
+12.9%
Q2 2014$11,984,000
-0.0%
2,663,170
-0.0%
0.15%
+0.7%
Q1 2014$11,986,000
-7.6%
2,663,520
+4.9%
0.15%
-8.2%
Q4 2013$12,973,000
+62.8%
2,538,760
+44.3%
0.16%
+37.1%
Q3 2013$7,968,000
+9.4%
1,758,955
+23.4%
0.12%
-2.5%
Q2 2013$7,285,0001,425,7050.12%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q4 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 188,703$557,0000.43%
Sterling Financial Planning, Inc. 22,031$65,0000.05%
BERKSHIRE ASSET MANAGEMENT LLC/PA 165,495$488,0000.04%
Ariel Investments 821,096$2,422,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 151,287$445,0000.01%
Renaissance Technologies 675,159$1,992,0000.00%
DIMENSIONAL FUND ADVISORS LP 781,891$2,299,0000.00%
Oakworth Capital, Inc. 3,052$9,0000.00%
ACADIAN ASSET MANAGEMENT LLC 105,018$310,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 53,441$157,0000.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders